Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as Thiomersal-free FluAS25 adjuvanted vaccine (GSK576389A)
Thiomersal-free FluAS25 adjuvanted vaccine · 1 trial · 1 indication
Titers were expressed as Geometric Mean Titers (GMTs). The three vaccine strains assessed included A/Solomon Islands, A/Wisconsin and B/Malaysia.
| Arm | Type | Description |
|---|---|---|
| Thiomersal-free FluAS25 adjuvanted vaccine group | EXPERIMENTAL | Subjects received 1 dose of thiomersal-free FluAS25 adjuvanted vaccine |
| Thiomersal reduced FluAS25 adjuvanted vaccine group | EXPERIMENTAL | Subjects received 1 dose of thiomersal reduced FluAS25 adjuvanted vaccine |
| Name | Type | Description |
|---|---|---|
| Thiomersal-free FluAS25 adjuvanted vaccine (GSK576389A) | BIOLOGICAL | Intramuscular administration, 1 dose |
| Thiomersal reduced FluAS25 adjuvanted vaccine (GSK576389A) | BIOLOGICAL | Intramuscular administration, 1 dose |
Inclusion Criteria: * Subjects who the investigator believes that they can and will comply with the requirements of the protocol should be enrolled in the study. * A male or female 65 years of age or older at the time of vaccination. * Written informed consent obtained from the subject. * Free of a...